In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Robert Welsh
Speaker
Robert Welsh
Robert Welsh Robert Welsh

Mazankowski Alberta Heart Institute, Edmonton (Canada)

Speciality : Interventional Cardiology

Robert Welsh is a professor and academic interventional cardiologist at the Mazankowski Alberta Heart Institute and University of Alberta in Edmonton, Alberta, Canada. He is Edmonton Zone Clinical Department Head, Cardiac Sciences, Co-chair of Vital Heart Response (STEMI regional reperfusion program) and the Mazankowski Alberta Heart Institute Transcatheter Aortic Valve Implantation program (TAVI). He is co-chair of the Canadian Cardiovascular Society PCI Quality Improvement working group. Clinical research interests are focused on the management of the full spectrum of acute coronary syndromes and interventional cardiology. Further research interests include diabetes mellitus and cardiac physiology. He has published over 200 peer-reviewed articles, multiple book chapters and over 175 scientific abstracts. In collaboration with colleagues, he has received a Canadian Institute of Health Research-Canadian Medical Association Journal Top Canadian Achievements in Health Research Award.

14 presentations from this speaker

How can we protect patients long-term after a percutaneous coronary intervention (PCI)?

Event : ESC Congress 2020

  • Session : Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond
  • Speaker : R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Welcome and introduction.

Event : ESC Congress 2020

  • Session : Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond
  • Speaker : R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Case clinic - Treating the patient who needs more

Event : ESC Congress 2019

  • Session : Vascular protection - Which of your patients with chronic coronary artery disease will benefit?
  • Speaker : G Montalescot (Paris,FR), R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Case clinic: treatment choices in patients with chronic CAD and diabetes

Event : ESC Congress 2019

  • Session : Vascular protection: practical insights
  • Speaker : R Welsh (Edmonton,CA), J Eikelboom (Hamilton,CA)
  • Sponsored by Bayer AG

Case clinic: why is risk stratification important?

Event : ESC Congress 2019

  • Session : Vascular protection: practical insights
  • Speaker : J Eikelboom (Hamilton,CA), R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Closing remarks

Event : ESC Congress 2019

  • Session : Vascular protection: practical insights
  • Speaker : R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Tailoring STEMI treatment to achieve optimal efficacy with minimal risk

Event : ESC Congress 2019

  • Session : STEMI care today: can we do better?
  • Speaker : R Welsh (Edmonton,CA)
  • Sponsored by Boehringer Ingelheim

There is still a place for thrombolysis in myocardial infarction - PRO

Event : ESC Congress 2019

  • Session : Emergency medicine: the French touch
  • Speaker : R Welsh (Edmonton,CA)

Cardiovascular protection: your questions answered.

Event : ESC Congress 2018

  • Session : Rivaroxaban in cardiovascular protection - Getting to the heart of the matter
  • Speaker : AJ Camm (London,GB), R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Evolution of pharmaco-invasive reperfusion for STEMI.

Event : ESC Congress 2018

  • Session : Spotlights on optimisation of guideline-supported reperfusion strategies for STEMI
  • Speaker : R Welsh (Edmonton,CA)
  • Sponsored by Boehringer Ingelheim

Managing the clinical challenges of the patient with atherothrombotic disease.

Event : ESC Congress 2018

  • Session : Rivaroxaban in cardiovascular protection - Getting to the heart of the matter
  • Speaker : M Cowie (London,GB), R Welsh (Edmonton,CA)
  • Sponsored by Bayer AG

Moderated discussion - Spotlights on optimisation of guideline-supported reperfusion strategies for STEMI.

Event : ESC Congress 2018

  • Session : Spotlights on optimisation of guideline-supported reperfusion strategies for STEMI
  • Speaker : K Huber (Vienna,AT), R Welsh (Edmonton,CA), N Danchin (Montreuil,FR), JK French (Sydney,AU), AC De Camargo Carvalho (Moema-Sao Paulo,BR)
  • Sponsored by Boehringer Ingelheim

Clinical importance of a STEMI network and pharmaco-invasive treatment.

Event : ESC Congress 2017

  • Session : Challenges and opportunities of establishing reperfusion networks for ST-segment elevation myocardial infarction (STEMI) and for acute stroke
  • Speaker : R Welsh (Edmonton,CA)
  • Sponsored by Boehringer Ingelheim International GmbH

Networks and reperfusion strategies for STEMI and ischaemic stroke: interactive discussion session.

Event : ESC Congress 2017

  • Session : Challenges and opportunities of establishing reperfusion networks for ST-segment elevation myocardial infarction (STEMI) and for acute stroke
  • Speaker : P Goldstein (Lille Cedex,FR), R Welsh (Edmonton,CA), C Molina (Barcelona,ES), PR Sinnaeve (Leuven,BE), D Leys (Lille,FR), PW Armstrong (Alberta,CA), F Van de Werf (Leuven,BE)
  • Sponsored by Boehringer Ingelheim International GmbH

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are